Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/s41569-022-00755-0.

Title:
AIMing 2 treat atherosclerosis | Nature Reviews Cardiology
Description:
The AIM2 inflammasome is activated by host and pathogen DNA. Work from the past 5 years indicates that the AIM2 inflammasome has an important role in advanced atherosclerosis driven by clonal haematopoiesis and possibly in atherosclerosis accelerated by acute infection. Therefore, the AIM2 inflammasome might be an important target for precision medicine.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Education
  • Social Networks

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.

Keywords {🔍}

nature, article, atherosclerosis, access, google, scholar, aim, inflammasome, content, cas, cookies, privacy, soehnlein, dna, open, inflammation, data, reviews, cardiology, oliver, diseases, mechanisms, therapeutic, crc, research, advertising, information, journals, subscribe, tall, role, clonal, medicine, institution, articles, immune, cardiovascular, portfolio, learn, buy, nlrp, science, nat, rev, receives, funding, münster, author, molecular, scientific,

Topics {✒️}

nature portfolio journals permissions reprints nature portfolio privacy policy advertising circulating cell-free dna scientific advisory board social media author information authors aim2 inflammasome-dependent pyroptosis nature+ nature 464 nature 592 nature 560 nature differential species-specific effects author correspondence personal data dna sensors aim2 data protection permissions springerlink instant access privacy therapeutic targets guido advanced atherosclerosis driven subscription content crc914 tp b8 crc1009 tp a13 crc1123 tp a6 aim2 inflammasome inflammasome activation european economic area explore content stroke stefan roth institutional subscriptions read kröner fresenius stiftung nih grants hl107653 commonwealth serum laboratories pattern recognition receptors panoptosis-related genes accepting optional cookies journals search log article soehnlein oliver soehnlein manage preferences pathogen dna issue learn münster medical faculty nat rev cardiol programmed death

Schema {🗺️}

WebPage:
      mainEntity:
         headline:AIMing 2 treat atherosclerosis
         description:The AIM2 inflammasome is activated by host and pathogen DNA. Work from the past 5 years indicates that the AIM2 inflammasome has an important role in advanced atherosclerosis driven by clonal haematopoiesis and possibly in atherosclerosis accelerated by acute infection. Therefore, the AIM2 inflammasome might be an important target for precision medicine.
         datePublished:2022-07-26T00:00:00Z
         dateModified:2022-07-26T00:00:00Z
         pageStart:567
         pageEnd:568
         sameAs:https://doi.org/10.1038/s41569-022-00755-0
         keywords:
            Cardiovascular diseases
            Inflammatory diseases
            Medicine/Public Health
            general
            Cardiology
            Cardiac Imaging
            Cardiac Surgery
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41569-022-00755-0/MediaObjects/41569_2022_755_Fig1_HTML.png
         isPartOf:
            name:Nature Reviews Cardiology
            issn:
               1759-5010
               1759-5002
            volumeNumber:19
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Oliver Soehnlein
               url:http://orcid.org/0000-0002-7854-0694
               affiliation:
                     name:University of Münster
                     address:
                        name:Institute of Experimental Pathology (ExPat), Center of Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
                        type:PostalAddress
                     type:Organization
                     name:Karolinska Institutet
                     address:
                        name:Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Alan R. Tall
               url:http://orcid.org/0000-0002-7708-2417
               affiliation:
                     name:Columbia University
                     address:
                        name:Division of Molecular Medicine, Department of Medicine, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:AIMing 2 treat atherosclerosis
      description:The AIM2 inflammasome is activated by host and pathogen DNA. Work from the past 5 years indicates that the AIM2 inflammasome has an important role in advanced atherosclerosis driven by clonal haematopoiesis and possibly in atherosclerosis accelerated by acute infection. Therefore, the AIM2 inflammasome might be an important target for precision medicine.
      datePublished:2022-07-26T00:00:00Z
      dateModified:2022-07-26T00:00:00Z
      pageStart:567
      pageEnd:568
      sameAs:https://doi.org/10.1038/s41569-022-00755-0
      keywords:
         Cardiovascular diseases
         Inflammatory diseases
         Medicine/Public Health
         general
         Cardiology
         Cardiac Imaging
         Cardiac Surgery
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41569-022-00755-0/MediaObjects/41569_2022_755_Fig1_HTML.png
      isPartOf:
         name:Nature Reviews Cardiology
         issn:
            1759-5010
            1759-5002
         volumeNumber:19
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Oliver Soehnlein
            url:http://orcid.org/0000-0002-7854-0694
            affiliation:
                  name:University of Münster
                  address:
                     name:Institute of Experimental Pathology (ExPat), Center of Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
                     type:PostalAddress
                  type:Organization
                  name:Karolinska Institutet
                  address:
                     name:Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Alan R. Tall
            url:http://orcid.org/0000-0002-7708-2417
            affiliation:
                  name:Columbia University
                  address:
                     name:Division of Molecular Medicine, Department of Medicine, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Reviews Cardiology
      issn:
         1759-5010
         1759-5002
      volumeNumber:19
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Münster
      address:
         name:Institute of Experimental Pathology (ExPat), Center of Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Columbia University
      address:
         name:Division of Molecular Medicine, Department of Medicine, Columbia University, New York, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Oliver Soehnlein
      url:http://orcid.org/0000-0002-7854-0694
      affiliation:
            name:University of Münster
            address:
               name:Institute of Experimental Pathology (ExPat), Center of Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
               type:PostalAddress
            type:Organization
            name:Karolinska Institutet
            address:
               name:Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Alan R. Tall
      url:http://orcid.org/0000-0002-7708-2417
      affiliation:
            name:Columbia University
            address:
               name:Division of Molecular Medicine, Department of Medicine, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Institute of Experimental Pathology (ExPat), Center of Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
      name:Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden
      name:Division of Molecular Medicine, Department of Medicine, Columbia University, New York, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(41)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Foundation
  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

3.63s.